Skip to main content
. 2023 Aug 11;16(6):961–983. doi: 10.1016/j.jcmgh.2023.08.005

Table 3.

Comparison of Demographic Information Between Patients With ≤T2 ESCC vs Patients With ≥T3 ESCC

≤T2 ≥T3 P value
Age, y 71 (62–77) 62.5 (55.8–74.3) .02
Female 18/66 (27%) 9/38 (24%) .81
Prior therapy 6/66 (9%) 6/38 (16%) .35

Values are median (interquartile range) or n/n (%).

ESCC, esophageal squamous cell carcinoma.